Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases

Hepatology. 2014 Aug;60(2):458-60. doi: 10.1002/hep.27061. Epub 2014 Jun 26.

Author

Suvro Chatterjee¹

Affiliation

¹ Vascular Biology Laboratory, AU-KBC Research Center, Chennai, India; Center for Biotechnology, Anna University, Chennai, India.

PMID: 24504762
DOI: 10.1002/hep.27061

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Animals
Cell Cycle Proteins / metabolism*
Humans
Liver Cirrhosis / metabolism*
Male
Neovascularization, Pathologic / metabolism*
Vascular Endothelial Growth Factor A / metabolism*

Substances

Cell Cycle Proteins
VASH1 protein, human
VASH1 protein, rat
VEGFA protein, human
Vascular Endothelial Growth Factor A
vascular endothelial growth factor A, rat